The low-down on high blood pressure - more focus on prevention and treatment goals

May 16, 2002

DALLAS, May 17 - Prevention, improving health habits and focusing on treatment goals are the cornerstone for future efforts to control hypertension - one of the nation's major health care burdens - according to an editorial in today's Hypertension: Journal of the American Heart Associaiton.

May is designated High Blood Pressure Month and this year marks the 30th anniversary of the National High Blood Pressure Education Program (NHBPEP), an initiative of the National Heart, Lung, and Blood Institute to get Americans to treat and control high blood pressure.

About 50 million Americans age six and older have high blood pressure, defined as systolic blood pressure (top number) of 140 millimeters of mercury (mm Hg) or higher, or diastolic pressure (bottom number) of 90 mm Hg or higher. Twenty years into the program, visits to physicians for high blood pressure had increased nearly 60 percent, whereas visits for all medical causes increased approximately 7 percent. The average systolic blood pressure has fallen more than 10 mm Hg. Deaths from stroke and coronary heart disease have fallen dramatically for men and women, as well as for white and black Americans in the last 30 years.

But, despite these successes, "We need to renew our efforts together to make sure that more people have their blood pressure measured, and their hypertension recognized and treated," says Daniel W. Jones, M.D., co-author of the editorial and associate dean of the school of medicine and professor of medicine at the University of Mississippi Medical Center, Jackson, Miss. Jones stresses that treatment itself is not the whole answer. He says physicians should make sure the treatment is effective in reducing blood pressures to the goal - the level identified as beneficial for preventing cardiovascular disease. According to American Heart Association statistics, more than 31 percent of people with high blood pressure are unaware they have it. In addition, 26.2 percent of people with high blood pressure are on medication for it, but do not have it under control.

"In the 30th year of the program, the treatment of hypertension is still inadequate and fails to reverse all of the risk for cardiovascular disease," he says. "Hypertension is still a public health problem that needs a better solution."

According to the authors, since the creation of NHBPEP, nearly all American adults have had their blood pressure measured, and most do so on a regular basis. In 1972, 16 percent of high blood pressure patients were controlled to the goal at the time of less than 160/95 mm Hg. A recent survey indicates that the control rate for today's goal of less than140/90 mm Hg is 29 percent.

Treatment to goal is especially critical when one considers the demographics of the aging population and rising trends in obesity and sedentary lifestyles says Jones. A recent analysis predicts that current middle-aged Americans face a 90 percent chance of developing high blood pressure some time during their lives, according to the editorial.

Cardiovascular disease is still the leading cause of death in this country. Current blood pressure goals may not be low enough, especially for people who have diabetes, according to Jones. The current goal for standard blood pressure is 140/90 mm Hg. For people with diabetes the goal is less than 130/85 mm Hg.

"There is increasing evidence that lower numbers are better. In recent years we have recognized that lower pressures are needed in certain groups, particularly those with diabetes. There's a good chance that the goals will continue to be reduced," he says.

In addition, the editorial cites that blood pressure control and cardiovascular disease rates are improving among minority ethnic groups in this country. However, these rates are not improving as fast as majority populations. "The gap that has existed for a number of years between majority and minority populations is actually widening, so we need to continue and renew our efforts in special populations," says Jones.
-end-
Dr. Jones' co-author is John E. Hall, Ph.D.

CONTACT: For journal copies only,
please call: (214) 706-1396
For other information, call:
Carole Bullock: (214) 706-1279
Maggie Francis: (214) 706-1397

American Heart Association

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.